After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
APLS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Apellis Pharmaceuticals Inc is $3.26B. A total of 1.19 million shares were traded on the day, compared to an average of 2.06M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, APLS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, DAVID OSBORNE WATSON bought 5,569 shares of APLS for 25.10 per share on Mar 05 ’25. In a previous transaction on Feb 11 ’25, DeLong Mark Jeffrey sold 363 shares at 28.54 per share. APLS shares that Chief Business & Strat Officer owns now total 83,945.
Among the insiders who bought shares, DeLong Mark Jeffrey acquired of 363 shares on Feb 11 ’25 at a per-share price of $28.54. In another insider transaction, Watson David O. sold 695 shares at $29.52 per share on Jan 29 ’25. Company shares held by the General Counsel now total 144,299.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for APLS in the last 3 months, the mean price target is $43.60 with high estimates of $75.00 and low estimates of $25.00. In terms of 52-week highs and lows, APLS has a high of $64.58 and a low of $23.77.
As of this writing, APLS has an earnings estimate of -$0.36 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.47.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $1.84, while its Total Shareholder’s Equity was $198.66M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APLS is Buy with a score of 4.23.
